Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Several lines of data previously indicated that N‐terminally truncated forms of amyloid‐β (Aβ) peptides are likely the earliest and more abundant species immunohistochemically detectable in Alzheimer’s disease‐affected brains. It is noteworthy that the free N‐terminal residue of full‐length Aβ (fl‐Aβ) is an aspartyl residue, suggesting that Aβ could be susceptible to exopeptidasic attack by aminopeptidase A (APA)‐like proteases. In this context, we have examined whether APA could target Aβ peptides in both cell‐free and cellular models. We first show that the general aminopeptidase inhibitor amastatin as well as two distinct aminopeptidase A inhibitors EC33 and pl302 both significantly increase the recovery of genuine fl‐Aβ peptides generated by cells over‐expressing Swedish‐mutated β amyloid precursor protein (APP) while the aminopeptidase N blocker pl250 did not modify fl‐Aβ recovery. In agreement with this observation, we establish that over‐expressed APA drastically reduces, in a calcium dependent manner, fl‐Aβ but not APP IntraCellular Domain in a cell‐free model of Aβ production. In agreement with the above data, we show that recombinant APA degrades fl‐Aβ in a pl302‐sensitive manner. Interestingly, we also show that EC33 and pl302 lower staurosporine‐stimulated activation of caspase‐3 in wild‐type fibroblasts but not in βAPP/β‐amyloid precursor protein‐like protein 2 (APLP2) double knockout fibroblasts, suggesting that protecting endogenous fl‐Aβ physiological production triggers neuroprotective phenotype. By contrast, EC33 does not modify staurosporine‐induced caspase‐3 activation in wild‐type and Swedish‐mutated βAPP‐HEK293 expressing cells that display exacerbated production of Aβ. Overall, our data establish that APA contributes to the N‐terminal truncation of Aβ and suggest that this cleavage is likely abrogating a protective function associated with physiological but not supraphysiological levels of genuine fl‐Aβ peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“3a) was first analyzed for the production of fl-Ab from a C100 recombinant fragment corresponding to the sequence theoretically derived from the sole attack of bAPP by b-secretase (Vassar et al. 1999).”
BackgroundThe molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447 · cited 1×
“Amyloid-b is a physiological product of bAPP processing (Shoji et al. 1992; Haass et al. 1993).”
BackgroundPike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587
Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain
Saido, T. C., Yamao-Harigaya, W., Iwatsubo, T., & Kawashima, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12970-0 · Cited by 270
Kuo, Y.-M., Emmerling, M. R., Woods, A. S., Cotter, R. J., & Roher, A. E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7083 · Cited by 178 · cited 2×
“1997), is a common denominator between diffuse and compact deposits (Saido et al. 1995; Kuo et al. 1997).”
BackgroundPresenilin-Dependent -Secretase-Mediated Control of p53-Associated Cell Death in Alzheimer's Disease
Alves da Costa, C., Sunyach, C., Pardossi-Piquard, R., Sevalle, J., Vincent, B., Boyer, N., Kawarai, T., Girardot, N., St. George-Hyslop, P., & Checler, F. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0651-06.2006 · Cited by 168
Self-citation
Cited by
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
Barage, S. H., & Sonawane, K. D. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.06.008 · Cited by 579
“…(Hu et al., 2001; Jalkute et al., 2013; Jalkute and Sonawane, 2015), cathepsin B (Mueller-Steiner et al., 2006;Wang et al., 2012), aminopeptidase (Sevalle et al., 2009; Dhanavade and Sonawane, 2014), gelatinase A (Yamada et al., 1995b; Jalkute et al., 2015), matrix metalloendopeptidase-9…”
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
Masters, C. L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006262 · Cited by 542
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
The role of astrocytes in amyloid production and Alzheimer's disease
Frost, G. R., & Li, Y.-M. (2017) · Open Biology · doi:10.1098/rsob.170228 · Cited by 435
Truncated and modified amyloid-beta species
Kummer, M. P., & Heneka, M. T. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt258 · Cited by 341
Metadata
- Authors
- Sevalle, J., Amoyel, A., Robert, P., Fournié‐Zaluski, M., Roques, B., & Checler, F.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2009-03-09
- Volume
- 109
- Issue
- 1
- Pages
- 248-256
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2039239447
- Cited by
- 108
- References
- 11
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide. https://app.cochat.ai/papers/10.1111/j.1471-4159.2009.05950.x
- The paper
- Sevalle, J., Amoyel, A., Robert, P., Fournié‐Zaluski, M., Roques, B., & Checler, F. (2009). Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2009.05950.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.